SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Ingrevia gets nod to raise Rs 600 crore via commercial papers

18 Aug 2023 Evaluate

Jubilant Ingrevia has received approval for raising of funds up to Rs 600 crore by issuance of Commercial Paper (CP). The members of the Finance Committee, at its meeting held on August 18, 2023 has considered and approved the same.  

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.


Jubilant Ingrevia Share Price

740.90 -2.95 (-0.40%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3865.25
Tata Chemicals 761.95
SRF 2798.45
Pidilite Inds. 1436.40
Deepak Nitrite 1861.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×